Condition: Endometrial Cancer · Ovarian Cancer · Ovarian Cancer Metastatic · Sponsor: Whitehawk Therapeutics, Inc.
HWK-007-101 is a multicenter, open-label, first-in-human (FIH) Phase 1 study evaluating HWK-007, a protein tyrosine kinase 7 (PTK7)-targeted antibody drug conjugate (ADC), in adult participants with advanced or metastatic solid tumors known to be expressing PTK7. The study employs a sequential dose escalation and dose expansion design without a control group.
This description comes directly from the study's public registry record.
Clinical Trial Manager Lead · 888-392-9025 · WHWK-Clinical-Trials@whitehawktx.com
Central email mailbox - Whitehawk Therapeutics · WHWK-Clinical-Trials@whitehawktx.com
Always discuss trial participation with your own doctor first.
| University of Arkansas | Little Rock, Arkansas, United States | Not Yet Recruiting |
| UCLA - Hematology/Oncology Clinical Research Unit | Los Angeles, California, United States | Not Yet Recruiting |
| St. Francis Medical Center (OSF Healthcare) | Peoria, Illinois, United States | Not Yet Recruiting |
| START - Midwest | Grand Rapids, Michigan, United States | Recruiting |
| Hackensack University Medical Center - John Theurer Cancer Center | Hackensack, New Jersey, United States | Not Yet Recruiting |
| Roswell Park Comprehensive Care Center | Buffalo, New York, United States | Not Yet Recruiting |
| University Hospital - Cleveland Medical Center | Cleveland, Ohio, United States | Not Yet Recruiting |
| NEXT Oncology - Austin | Austin, Texas, United States | Recruiting |
| NEXT - Oncology - Houston | Houston, Texas, United States | Recruiting |
| START - San Antonio | San Antonio, Texas, United States | Recruiting |
| NEXT Oncology - Virginia Cancer Specialists | Fairfax, Virginia, United States | Recruiting |
| Fred Hutchinson Cancer Center | Seattle, Washington, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07444814